| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | FABP 1 ELISA Kit; FABP1 ELISA Kit; FABPL ELISA Kit; FABPL_HUMAN ELISA Kit; Fatty Acid Binding Protein 1 ELISA Kit; Fatty acid binding protein 1 liver ELISA Kit; Fatty Acid Binding Protein ELISA Kit; Fatty acid-binding protein 1 ELISA Kit; Fatty acid-binding protein ELISA Kit; Fatty acid-binding protein liver ELISA Kit; L FABP ELISA Kit; L-FABP ELISA Kit; liver ELISA Kit; Liver-type fatty acid-binding protein ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, cell culture supernates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Liver Type Fatty Acid Binding Protein(L-FABP) (FABP1) is a biological molecule commonly studied in signal transduction research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P07148
Biological context
Researchers often monitor Liver Type Fatty Acid Binding Protein(L-FABP) in serum, plasma, and cell culture supernates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Liver Type Fatty Acid Binding Protein(L-FABP) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Liver Type Fatty Acid Binding Protein(L-FABP) may also appear under names such as FABP 1 and FABP1. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Liver Type Fatty Acid Binding Protein(L-FABP) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
L-FABP as a Potential Biomolecular Marker of Liver Graft Injury
A Kalamutova, D Plevel, M Djokic, A Jerin,Journal of Clinical Medicine,2025
Serum biomarkers of isoniazid‐induced liver injury: Aminotransferases are insufficient, and OPN, L‐FABP and HMGB1 can be promising novel biomarkers
X Cheng,Journal of applied toxicology,2023
Energy Homeostasis Gene Nucleotide Variants and Survival of Hemodialysis Patients—A Genetic Cohort Study
MK Świderska,Journal of Clinical Medicine,2022
Urinary Liver Type Fatty Acid Binding Protein Is Negatively Associated With Estimated Glomerular Filtration Rate in Renal Transplant Recipients With Graft Loss
Y.-C.Huang.et al,Transplantation Proceedings,2018
Prevention mechanism of 2, 3, 5, 4'-tetrahydroxy-stilbene-2-O-B-D-glucoside on lipid accumulation in steatosis hepatic L-02 cell
Wang W.et al,J Ethnopharmacol. ,2017
Is there an association between liver type fatty acid binding protein and severity of preeclampsia?
Uzunlar O.et al,Arch Gynecol Obstet.,2015